Wednesday, November 15, 2017 3:14:30 PM
TheNewswire / Hamilton, ON, November 14, 2017
CTT Pharmaceuticals Holdings, Inc., an innovative life sciences company which provides disruptive proprietary drug delivery technologies designed to improve patient outcomes and experiences, today would like to provide a corporate update.
2017 YTD Achievements and Anticipated Goals
- CanniMed Therapeutics, our exclusive Canadian licensee in the Medical Cannabis industry has submitted it's application to Health Canada in regards to our proprietary sub-lingual wafer.
- US Patent and Trademark Office has issued US Patent # 14921501. This brings our patent portfolio to 4 issued patents, 2 pending and a PCT.
- Annual Report for 2016 has just been submitted to the OTC Markets and the 3 quarters of 2017 are currently being prepared and will be filed shortly.
- Currently in discussions with potential joint-venture partners and Pharmaceutical companies to license and commercialize various applications of it's Oral Thin Film Wafer.
"We expect to be formalizing our agreements with our potential joint-venture partners shortly" said Dr Pankaj Modi, CEO of CTT Pharmaceuticals, " In addition we are moving forward with our exclusive Canadian licensee CanniMed Therapeutics in obtaining Health Canada's approval for our Oral Thin Film Wafer"
Recent CTTH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/11/2024 06:01:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/27/2024 07:58:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 06:17:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 01:45:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 02:45:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/26/2024 12:04:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 08:33:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 08:26:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/31/2023 06:04:29 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM